Minister for IT and Major Industries K T Rama Rao said that Hyderabad has the position as the “vaccine capital of the world” and it was further bolstered.
He said that it is a matter of pride that the world is looking to India and Hyderabad after inaugurating the 18th edition of BioAsia.Hyderabad’s scientists and entrepreneurs have given the life sciences sector its moment in the spotlight amidst the pandemic, with the accelerated development of vaccines, diagnostics and therapeutics. The city rose to the occasion and made an impact for the world to witness he stated.
The Prime Minister Narendra Modis visit to Genome Valley is a testimony to the cluster’s significance in the global context,” added the Minister.He praised Bharat Biotech’s contribution and commitment to develop India’s first indigenous vaccine for Covid-19, and the efforts of Biological E, Indian Immunologicals and others in vaccine development.
KTR added, Hetero Pharma and Dr Reddy’s are also augmenting the global supply by manufacturing and distributing Russian vaccine Sputnik. Further, Aurobindo Pharma is building a world-class vaccine manufacturing facility with a capacity of about 450 million doses.
All these highlights the position of Hyderabad as the vaccine capital of the world and significant global population will be immunised with vaccines produced in Hyderabad.
“Our dream and vision of growing the life sciences industry to over $100 billion looks plausible and we remain committed to it the Minister added.
I would like to highlight that even after the widespread health and economic distress caused by Covid-19 pandemic, the life sciences sector in Telangana has responded with resilience and witnessed tremendous growth during the year.
Life sciences sector in the State has attracted investments to the tune of about Rs 3,700 crores in last one year with an employment potential for around 14,000 people.”
